210 related articles for article (PubMed ID: 34419573)
1. Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.
Glücklich N; Carle S; Buske J; Mäder K; Garidel P
Eur J Pharm Sci; 2021 Nov; 166():105980. PubMed ID: 34419573
[TBL] [Abstract][Full Text] [Related]
2. How enzymatic hydrolysis of polysorbate 20 influences colloidal protein stability.
Glücklich N; Carle S; Diederichs T; Buske J; Mäder K; Garidel P
Eur J Pharm Sci; 2023 Dec; 191():106597. PubMed ID: 37770006
[TBL] [Abstract][Full Text] [Related]
3. An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80.
Glücklich N; Dwivedi M; Carle S; Buske J; Mäder K; Garidel P
Int J Pharm; 2020 Dec; 591():119934. PubMed ID: 33059015
[TBL] [Abstract][Full Text] [Related]
4. Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins.
Aryal B; Lehtimaki M; Rao VA
Pharm Res; 2024 Jun; 41(6):1217-1232. PubMed ID: 38740663
[TBL] [Abstract][Full Text] [Related]
5. Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay.
Lippold S; Koshari SHS; Kopf R; Schuller R; Buckel T; Zarraga IE; Koehn H
J Pharm Biomed Anal; 2017 Jan; 132():24-34. PubMed ID: 27693757
[TBL] [Abstract][Full Text] [Related]
6. All-in-one stability indicating polysorbate 20 degradation root-cause analytics via UPLC-QDa.
Carle S; Evers DH; Hagelskamp E; Garidel P; Buske J
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123955. PubMed ID: 38128165
[TBL] [Abstract][Full Text] [Related]
7. Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.
Dwivedi M; Buske J; Haemmerling F; Blech M; Garidel P
Eur J Pharm Sci; 2020 Mar; 144():105211. PubMed ID: 31931121
[TBL] [Abstract][Full Text] [Related]
8. Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method.
Zhang S; Riccardi C; Kamen D; Xiao H; Li N
Anal Biochem; 2022 Jan; 637():114472. PubMed ID: 34801481
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.
Doshi N; Giddings J; Luis L; Wu A; Ritchie K; Liu W; Chan W; Taing R; Chu J; Sreedhara A; Kannan A; Kei P; Shieh I; Graf T; Hu M
Pharm Res; 2021 Mar; 38(3):531-548. PubMed ID: 33713012
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of Polysorbate 20 and 80 by a Range of Carboxylester Hydrolases.
McShan AC; Kei P; Ji JA; Kim DC; Wang YJ
PDA J Pharm Sci Technol; 2016; 70(4):332-45. PubMed ID: 27020650
[TBL] [Abstract][Full Text] [Related]
11. Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.
Zhang S; Xiao H; Li N
J Pharm Sci; 2021 Dec; 110(12):3866-3873. PubMed ID: 34487744
[TBL] [Abstract][Full Text] [Related]
12. Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases.
Zhang S; Riccardi C; Kamen D; Reilly J; Mattila J; Bak H; Xiao H; Li N
Pharm Res; 2022 Jan; 39(1):75-87. PubMed ID: 34981317
[TBL] [Abstract][Full Text] [Related]
13. The Characterization of Polysorbate.
Zhang S; Xiao H; Li N
Curr Protoc; 2022 Jul; 2(7):e489. PubMed ID: 35857882
[TBL] [Abstract][Full Text] [Related]
14. Prediction of long-term polysorbate degradation according to short-term degradation kinetics.
Zhang S; Riccardi C; Carlson D; Kamen D; Graham KS; Shameem M; Bak H; Xiao H; Li N
MAbs; 2023; 15(1):2232486. PubMed ID: 37415319
[TBL] [Abstract][Full Text] [Related]
15. Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate Degradation.
Roy I; Patel A; Kumar V; Nanda T; Assenberg R; Wuchner K; Amin K
J Pharm Sci; 2021 Sep; 110(9):3313-3323. PubMed ID: 34077768
[TBL] [Abstract][Full Text] [Related]
16. Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation.
Doshi N; Martin J; Tomlinson A
Mol Pharm; 2020 Nov; 17(11):4354-4363. PubMed ID: 32941040
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations.
Gregoritza K; Theodorou C; Heitz M; Graf T; Germershaus O; Gregoritza M
Eur J Pharm Biopharm; 2024 Jan; 194():74-84. PubMed ID: 38042510
[TBL] [Abstract][Full Text] [Related]
18. Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation.
Kranz W; Wuchner K; Corradini E; Berger M; Hawe A
J Pharm Sci; 2019 Jun; 108(6):2022-2032. PubMed ID: 30639738
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Recombinantly-Expressed Hydrolytic Enzymes from Chinese Hamster Ovary Cells: Identification of Host Cell Proteins that Degrade Polysorbate.
Kovner D; Yuk IH; Shen A; Li H; Graf T; Gupta S; Liu W; Tomlinson A
J Pharm Sci; 2023 May; 112(5):1351-1363. PubMed ID: 36646283
[TBL] [Abstract][Full Text] [Related]
20. Measuring Lipolytic Activity to Support Process Improvements to Manage Lipase-Mediated Polysorbate Degradation.
Jahn M; Zerr A; Fedorowicz FM; Brigger F; Koulov A; Mahler HC
Pharm Res; 2020 Jun; 37(6):118. PubMed ID: 32495187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
